Literature DB >> 23743193

Suppressed circulating bicyclo-PGE2 levels and leukocyte COX-2 transcripts in children co-infected with P. falciparum malaria and HIV-1 or bacteremia.

Samuel B Anyona1, Prakasha Kempaiah, Gregory C Davenport, John M Vulule, James B Hittner, John M Ong'echa, Douglas J Perkins.   

Abstract

In holoendemic Plasmodium falciparum transmission regions, malarial anemia is a leading cause of childhood morbidity and mortality. Identifying biomarkers of malaria disease severity is important for identifying at-risk groups and for improved understanding of the molecular pathways that influence clinical outcomes. We have previously shown that decreased cyclooxygenase (COX)-2-derived prostaglandin E2 (PGE2) levels are associated with enhanced clinical severity in cerebral malaria, malarial anemia, and malaria during pregnancy. Since children with malaria often have increased incidence of additional infections, such as bacteremia and HIV-1, we extend our previous findings by investigating COX-2 and PGE2 in children with falciparum malaria and co-infection with either bacteremia or HIV-1. Plasma bicyclo-PGE2/creatinine levels and peripheral blood COX-2 transcripts were significantly reduced in co-infected children relative to those with malaria mono-infection. Furthermore, suppression of circulating bicyclo-PGE2 was significantly associated with reduced hemoglobin levels in both mono- and co-infected children with malaria, suggesting that bicyclo-PGE2 may represent both a marker and mediator of malaria pathogenesis.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anemia; Bacteremia; COX-2; HIV-1; PGE(2); SMA

Mesh:

Substances:

Year:  2013        PMID: 23743193      PMCID: PMC4703399          DOI: 10.1016/j.bbrc.2013.05.089

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  52 in total

Review 1.  Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster.

Authors: 
Journal:  Trans R Soc Trop Med Hyg       Date:  2000-04       Impact factor: 2.184

2.  Reduced systemic bicyclo-prostaglandin-E2 and cyclooxygenase-2 gene expression are associated with inefficient erythropoiesis and enhanced uptake of monocytic hemozoin in children with severe malarial anemia.

Authors:  Samuel B Anyona; Prakasha Kempaiah; Evans Raballah; Gregory C Davenport; Tom Were; Stephen N Konah; John M Vulule; James B Hittner; Charity W Gichuki; John M Ong'echa; Douglas J Perkins
Journal:  Am J Hematol       Date:  2012-06-23       Impact factor: 10.047

3.  The effect of HIV and HPV coinfection on cervical COX-2 expression and systemic prostaglandin E2 levels.

Authors:  Daniel W Fitzgerald; Karl Bezak; Oksana Ocheretina; Cynthia Riviere; Thomas C Wright; Ginger L Milne; Xi Kathy Zhou; Baoheng Du; Kotha Subbaramaiah; Erin Byrt; Matthew L Goodwin; Arash Rafii; Andrew J Dannenberg
Journal:  Cancer Prev Res (Phila)       Date:  2011-12-01

4.  Impaired systemic production of prostaglandin E2 in children with cerebral malaria.

Authors:  Douglas J Perkins; James B Hittner; Esther D Mwaikambo; Donald L Granger; J Brice Weinberg; Nicholas M Anstey
Journal:  J Infect Dis       Date:  2005-03-31       Impact factor: 5.226

5.  Identification of inflammatory biomarkers for pediatric malarial anemia severity using novel statistical methods.

Authors:  John M Ong'echa; Gregory C Davenport; John M Vulule; James B Hittner; Douglas J Perkins
Journal:  Infect Immun       Date:  2011-08-22       Impact factor: 3.441

6.  Focal accumulation of cyclooxygenase-1 (COX-1) and COX-2 expressing cells in cerebral malaria.

Authors:  M H Deininger; P G Kremsner; R Meyermann; H J Schluesener
Journal:  J Neuroimmunol       Date:  2000-07-01       Impact factor: 3.478

7.  Bacteremia in Kenyan children presenting with malaria.

Authors:  T Were; G C Davenport; J B Hittner; C Ouma; J M Vulule; J M Ong'echa; D J Perkins
Journal:  J Clin Microbiol       Date:  2010-11-24       Impact factor: 5.948

8.  A role for parasite-induced PGE2 in IL-10-mediated host immunoregulation by skin stage schistosomula of Schistosoma mansoni.

Authors:  K Ramaswamy; P Kumar; Y X He
Journal:  J Immunol       Date:  2000-10-15       Impact factor: 5.422

9.  Relationship between inflammatory mediator patterns and anemia in HIV-1 positive and exposed children with Plasmodium falciparum malaria.

Authors:  Gregory C Davenport; James B Hittner; Tom Were; John M Ong'echa; Douglas J Perkins
Journal:  Am J Hematol       Date:  2012-05-08       Impact factor: 10.047

Review 10.  Severe malarial anemia: innate immunity and pathogenesis.

Authors:  Douglas J Perkins; Tom Were; Gregory C Davenport; Prakasha Kempaiah; James B Hittner; John Michael Ong'echa
Journal:  Int J Biol Sci       Date:  2011-11-02       Impact factor: 6.580

View more
  5 in total

1.  Concentrations of PGE2 and TXB2 in the Eyes of Mice with Disseminated Acanthamoebiasis.

Authors:  Karolina Kot; Daria Kołodziej; Patrycja Kupnicka; Danuta Izabela Kosik-Bogacka; Natalia Łanocha-Arendarczyk
Journal:  Pathogens       Date:  2022-04-04

2.  Expression and Activity of COX-1 and COX-2 in Acanthamoeba sp.-Infected Lungs According to the Host Immunological Status.

Authors:  Natalia Łanocha-Arendarczyk; Irena Baranowska-Bosiacka; Karolina Kot; Izabela Gutowska; Agnieszka Kolasa-Wołosiuk; Dariusz Chlubek; Danuta Kosik-Bogacka
Journal:  Int J Mol Sci       Date:  2018-01-02       Impact factor: 5.923

Review 3.  Lipid Droplet, a Key Player in Host-Parasite Interactions.

Authors:  Adriana Lima Vallochi; Livia Teixeira; Karina da Silva Oliveira; Clarissa Menezes Maya-Monteiro; Patricia T Bozza
Journal:  Front Immunol       Date:  2018-05-23       Impact factor: 7.561

Review 4.  Prostanoid Metabolites as Biomarkers in Human Disease.

Authors:  Helena Idborg; Sven-Christian Pawelzik
Journal:  Metabolites       Date:  2022-08-04

Review 5.  Malaria and HIV coinfection in sub-Saharan Africa: prevalence, impact, and treatment strategies.

Authors:  Tebit E Kwenti
Journal:  Res Rep Trop Med       Date:  2018-07-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.